Clinical Trial Update: PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)

View source ↗

Summary

Update on the PELICAN trial evaluating PSMA PET imaging to assess treatment response to systemic therapies in metastatic prostate cancer; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: PSMA Positive Tumors or Tumor Tissues, Prostate Cancer Metastatic | Status: RECRUITING